These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18446501)

  • 61. National Institutes of Health Funding to Departments of Orthopaedic Surgery at U.S. Medical Schools.
    Silvestre J; Ahn J; Levin LS
    J Bone Joint Surg Am; 2017 Jan; 99(2):e5. PubMed ID: 28099310
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The changing roles of industry and academia.
    Bauer EA; Cohen DE
    J Invest Dermatol; 2012 Mar; 132(3 Pt 2):1033-6. PubMed ID: 22330271
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Bridging the gap between research, policy, and practice: Lessons learned from academic-public partnerships in the CTSA network.
    Towfighi A; Orechwa AZ; Aragón TJ; Atkins M; Brown AF; Brown J; Carrasquillo O; Carson S; Fleisher P; Gustafson E; Herman DK; Inkelas M; Liu W; Meeker D; Mehta T; Miller DC; Paul-Brutus R; Potter MB; Ritner SS; Rodriguez B; Rusch D; Skinner A; Yee HF
    J Clin Transl Sci; 2020 Mar; 4(3):201-208. PubMed ID: 32695489
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Opportunities for chemical biologists: a view from the National Institutes of Health.
    Berg JM
    ACS Chem Biol; 2006 Oct; 1(9):547-8. PubMed ID: 17168545
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Temporal evolution of biomedical research grant collaborations across multiple scales--a CTSA baseline study.
    Nagarajan R; Lowery CL; Hogan WR
    AMIA Annu Symp Proc; 2011; 2011():987-93. PubMed ID: 22195158
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CTSA Institution Responses to Proposed Common Rule Changes: Did They Get What They Wanted?
    Rivera SM; Nichols L; Brako L; Croft G; Russo T; Tran T
    J Empir Res Hum Res Ethics; 2017 Apr; 12(2):79-86. PubMed ID: 28421883
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The patient-physician-industry-government partnership: a societal good.
    Frishman WH
    Am J Med; 2009 Oct; 122(10):886-7. PubMed ID: 19786152
    [No Abstract]   [Full Text] [Related]  

  • 68. Industry-sponsored clinical research: a broken system.
    Angell M
    JAMA; 2008 Sep; 300(9):1069-71. PubMed ID: 18768418
    [No Abstract]   [Full Text] [Related]  

  • 69. Effect of the experience of surgical chairpersons on departmental National Institutes of Health funding.
    Jayakrishnan TT; Green DE; Hwang M; Zacharias AJ; Sharma A; Johnston FM; Gamblin TC; Turaga KK
    J Surg Res; 2014 Dec; 192(2):293-7. PubMed ID: 25240287
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Family medicine, the NIH, and the medical-research roadmap: perspectives from inside the NIH.
    Lucan SC; Barg FK; Bazemore AW; Phillips RL
    Fam Med; 2009 Mar; 41(3):188-96. PubMed ID: 19259841
    [TBL] [Abstract][Full Text] [Related]  

  • 71. New and evolving rare diseases research programs at the National Institutes of Health.
    Groft SC; Rubinstein YR
    Public Health Genomics; 2013; 16(6):259-67. PubMed ID: 24503586
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Basic and translational research in neonatal pharmacology.
    Ward RM; Lane RH; Albertine KH
    J Perinatol; 2006 Jul; 26 Suppl 2():S8-S12. PubMed ID: 16801973
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fundamental problems lie ahead in the drug discovery and commercialization process: restructuring of the pharmaceutical industry and an improved partnership with academia are required.
    Brewer GJ
    J Investig Med; 2006 Sep; 54(6):291-302. PubMed ID: 17191351
    [No Abstract]   [Full Text] [Related]  

  • 74. Unique characteristics of emergency care research: scope, populations, and infrastructure.
    Courtney DM; Neumar RW; Venkatesh AK; Kaji AH; Cairns CB; Lavonas E; Richardson LD
    Acad Emerg Med; 2009 Oct; 16(10):990-4. PubMed ID: 19799578
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Developing gene and cell therapies for rare diseases: an opportunity for synergy between academia and industry.
    Mavilio F
    Gene Ther; 2017 Sep; 24(9):590-592. PubMed ID: 28485723
    [TBL] [Abstract][Full Text] [Related]  

  • 76. CAM evaluation comes into the mainstream: NIH specialized Centers of research and the University of Maryland Center for Alternative Medicine Research in Arthritis.
    Berman BM; Hartnoll S; Bausell B
    Complement Ther Med; 2000 Jun; 8(2):119-22. PubMed ID: 10859605
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Collaboration Platforms in China for Translational and Clinical Research: The Partnership Between Peking University Health Science Center and the University of Michigan Medical School.
    Kolars JC; Fang W; Zheng K; Huang AY; Sun Q; Wang Y; Woolliscroft JO; Ke Y
    Acad Med; 2017 Mar; 92(3):370-373. PubMed ID: 27119322
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Expanding the scope of responsible conduct of research instruction.
    Resnik DB; Stewart CN
    Account Res; 2014; 21(5):321-7. PubMed ID: 24625184
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Managing the interface between medical schools, hospitals, and clinical research.
    Gallin JI; Smits HL
    JAMA; 1997 Feb; 277(8):651-4. PubMed ID: 9039884
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An exploratory study of Clinical and Translational Science Award community-engaged research training programs.
    Ziegahn L; Nevarez L; Hurd T; Evans J; Joosten Y; Dumbauld J; Eder MM
    J Clin Transl Sci; 2018 Apr; 2(2):110-114. PubMed ID: 31660224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.